Category: Medical Recalls
If you’ve been affected by the Oculentis recall and you’ve yet to speak to our specialist team about compensation, please get in touch as soon as you can.
With medical product claims like this, there can be a number of timeframes that you may fall foul of if you don’t launch legal action quickly enough. With some people who are having problems not suffering any issues until more than five years post-surgery, we need to be careful when calculating the limitation dates to claim.
Our advice is always the same: start a compensation case as soon you can. You may be eligible to claim compensation if you’re affected by the Oculentis recall, so there’s no need to wait.
There’s been a recall during the summer over valsartan cancer risks that have been identified. A recall has been triggered by regulators.
The Medicines and Healthcare products Regulatory Agency (MHRA) has been involved in the recall process. The recall has been triggered over impurities originating from the manufacturing process in China. The impurities are understood to be linked to cancer.
Patients using heart medications that contain valsartan are being asked to speak to their doctor or pharmacist ASAP.
We are very pleased to see that the NHS has finally put a ban on mesh operations as a result of continuing mesh implant problems.
Mesh implant problems have been known for a long time now, and the complications that patients can suffer from are often permanent and incredibly severe. There have been a number of investigations leading to the MHRA previously suggesting that the benefits outweighed the risks of the procedure, before the introduction of guidelines introduced by NICE (The National Institute for Health and Care Excellence). Now, there is a total pause on the procedures altogether in most cases.
We welcome the news as we have been advising people who have suffered mesh implant problems for years.
Lupin Pharmaceuticals Inc. have made a horrendous error with their packaging which could mess up birth control plans for many women.
On 30th May 2017, Lupin Pharmaceuticals Inc. announced a recall for one lot of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1mg/0.02mg chewable and ferrous fumarate 75mg) tablets after a customer complained there had been a mix-up with the packaging, missing expiry dates and incorrect lot information.
There’s a concern that the mix-up could result in women taking chemically inactive pills on days when they should be taking active tablets, and therefore risk unintended pregnancy.
Read More “Packaging mix-up of birth control pills could lead to unintended pregnancies”
Medtronic, a global leader in medical technology, has recently taken a few medical devices off the market as a result of multiple complaints and one reported death.
In this case, Medtronic issued a voluntary recall of the StrataMR valve and shunt.
The device was created to manage hydrocephalus – a condition where there is an accumulation of cerebrospinal fluid (CSF) within the brain. Unfortunately, concerns have been raised about the safety of the devices.
Read More “Brain fluid drainage device recalled due to multiple complaints”